Foley, Matthew H. http://orcid.org/0000-0002-3116-2040
Walker, Morgan E. http://orcid.org/0000-0002-0234-1939
Stewart, Allison K.
O’Flaherty, Sarah http://orcid.org/0000-0001-8629-0675
Gentry, Emily C. http://orcid.org/0000-0002-0016-8132
Patel, Shakshi http://orcid.org/0000-0002-6164-0824
Beaty, Violet V.
Allen, Garrison
Pan, Meichen
Simpson, Joshua B.
Perkins, Caroline
Vanhoy, Molly E.
Dougherty, Michael K.
McGill, Sarah K.
Gulati, Ajay S. http://orcid.org/0000-0002-7612-6369
Dorrestein, Pieter C. http://orcid.org/0000-0002-3003-1030
Baker, Erin S. http://orcid.org/0000-0001-5246-2213
Redinbo, Matthew R. http://orcid.org/0000-0003-0814-5346
Barrangou, Rodolphe http://orcid.org/0000-0002-0648-3504
Theriot, Casey M. http://orcid.org/0000-0002-1895-8941
Funding for this research was provided by:
NCTraCS Translational and Clinical Sciences Institute Pilot Award UNCSUR11609 and Funding from IFF.
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (T32GM008570)
U.S. Department of Health & Human Services | NIH | National Institute of Environmental Health Sciences (P42 ES027704)
Article History
Received: 16 November 2022
Accepted: 8 February 2023
First Online: 13 March 2023
Competing interests
: M.R.R. is a founder of Symberix, Inc. and the recipient of research funding from Merck and Lilly, although those funds were not used in this project. P.C.D. is a scientific advisor to Cybele and is a co-founder and scientific founder of Ometa and Enveda, with previous approval by UC-San Diego. C.M.T. consults for Vedanta Biosciences, Inc., Summit Therapeutics, and Ferring Pharmaceuticals, Inc. R.B. is a founder of Ancilia Biosciences. M.H.F., S.O'F., R.B. and C.M.T. are inventors on a patent application (US patent application no. 17609283 submitted on 7 July 2022) related to the use of <i>Lactobacillus</i> BSH enzymes. The other authors declare no competing interests.